Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD
5.23
+0.09 (1.75%)
May 7, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Sales of Pharmaceutical Products and Research and Development of New Drugs | 934.87M | 367.79M | 225.35M | 15.57M | - | | |
Sales of Pharmaceutical Products and Research and Development of New Drugs Growth | 154.18% | 63.21% | 1347.16% | - | - | | |
| 934.87M | 367.79M | 225.35M | 15.57M | - | | |
| 154.18% | 63.21% | 1347.16% | - | - | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
People's Republic of China (PRC) | 571.08M | 345.83M | 101.39M | 15.57M | - | | |
People's Republic of China (PRC) Growth | 65.13% | 241.11% | 551.07% | - | - | | |
| 363.79M | 21.96M | 123.97M | - | - | | |
| 1556.30% | -82.28% | - | - | - | | |
| 934.87M | 367.79M | 225.35M | 15.57M | - | | |
| 154.18% | 63.21% | 1347.16% | - | - | | |
Source: S&P Global Market Intelligence.
